Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.

about

Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.

Item

http://www.wikidata.org/entity/Q35887012

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Persistence of immunity in hea ...... B vaccine 3 years previously.

@ast

Persistence of immunity in hea ...... B vaccine 3 years previously.

@en

type

Item

label

Persistence of immunity in hea ...... B vaccine 3 years previously.

@ast

Persistence of immunity in hea ...... B vaccine 3 years previously.

@en

prefLabel

Persistence of immunity in hea ...... B vaccine 3 years previously.

@ast

Persistence of immunity in hea ...... B vaccine 3 years previously.

@en

P1476

Persistence of immunity in hea ...... B vaccine 3 years previously.

@en

P2093

Anthony Dowell

http://www.w3.org/2001/XMLSchema#string

Clas Ahlm

http://www.w3.org/2001/XMLSchema#string

Clément Tran

http://www.w3.org/2001/XMLSchema#string

Cécile Eymin

http://www.w3.org/2001/XMLSchema#string

Rajiv Sharma

http://www.w3.org/2001/XMLSchema#string

Stéphane Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Natural History and Clinical Consequences of Hepatitis B Virus Infection

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.

The immune system in the elderly: I. Specific humoral immunity.

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.

Why aging T cells fail: implications for vaccination.

Biology of immune responses to vaccines in elderly persons.

B-cell responses to vaccination at the extremes of age.

Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine

Immunosenescence and vaccine failure in the elderly.

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers.

P304

1709-1716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1019187

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lars Østergaard

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25996838

http://www.w3.org/2001/XMLSchema#string

P932

4514216

http://www.w3.org/2001/XMLSchema#string